£100
No changevs Mar 2024Active14715981Private limited companyLondon
BYRD BIOSCIENCES LTD
Significant control: Professor David Keays (50–75%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Byrd Biosciences Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Byrd Biosciences Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
BYRD BIOSCIENCES LTD is an active private limited company (company number 14715981) incorporated on 8 March 2023, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest dormant accounts cover the period ending 31 March 2025, showing net assets of £100, with 0 employees on average. Net assets were unchanged on the prior period.
Peer position · net assets
By net assets it sits in the lower half of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
- Professor David Keays
- owns 50–75% of shares
- owns 50–75% of shares
- holds 50–75% of voting rights
- holds 50–75% of voting rights
- can appoint or remove directors
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 8 March 20233 yrs ago
- Next accounts due
- 31 December 2026in 68 days
- Confirmation statement due
- 22 March 2027in 149 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Dormant
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not reported
0
vs Mar 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £100 | — | £100 | — | — | — | 0 |
| 31 March 2024 | £100 | — | £100 | — | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £100 at 31 March 2025
- Incorporated two to five years agoIncorporated 8 March 2023
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 149 days
- Next accounts duein 68 days
- Accounts period endNet assets £100 · dormant accounts
- Accounts period endNet assets £100 · dormant accounts
- Incorporated
08
Similar companies in London
- AXOVIA THERAPEUTICS LTDLondon · inc. Mar 2023
- AEON 5 LIMITEDLondon · inc. Mar 2023
- ZONOVA TECHNOLOGIES LTDLondon · inc. Mar 2023
- WOODSIDE UROL HEALTH LIMITEDLondon · inc. Mar 2023
- VANTAGE BIOSCIENCES LTDLondon · inc. Mar 2023
- MBPHARMACO CONSULTING LTDLondon · inc. Mar 2023
All companies incorporated on 8 March 2023 · in Mar 2023.
09
Reminders for BYRD BIOSCIENCES LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.